H-CYTE (OTCMKTS:HCYTD) Shares Down 49.5% – Time to Sell?

H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s share price traded down 49.5% during trading on Wednesday . The stock traded as low as $2.02 and last traded at $2.02. Approximately 400 shares traded hands during trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.

H-CYTE Stock Performance

The business’s 50-day moving average price is $2.02 and its two-hundred day moving average price is $2.02.

About H-CYTE

(Get Free Report)

H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

See Also

• Five stocks we like better than H-CYTE
• Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
• Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
• Apple’s Record Quarter Could Not Outrun Its Guidance Problem
• McKesson’s Compounding Keeps Adding Up